September 30th, 2021 Like most chronic respiratory diseases, the burden of living with
chronic pulmonary hypertension (PH) impacts of patients' daily life. In the journal this month …

The Pulmonary Hypertension Association Registry (PHAR) is an ongoing large multi‐center
registry of patients with pulmonary arterial hypertension and chronic thromboembolic …

In this conference paper, we review the 2020 American Thoracic Society International
Conference session titled,“What's New in Pulmonary Hypertension Clinical Research …

Dear Editors, The authors would like to make a correction to the article, Health disparities
and treatment approaches in portopulmonary hypertension and idiopathic pulmonary …

© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2016; 8 (Suppl 7): S562-
S565 jtd. amegroups. com driven trials including< 300 individuals to significantly larger …

We ran a PubMed search for PVD researchers and found that, of all the authors of published
articles on PVD, 90.3% were from the United States, Canada, the United Kingdom, France …

PURPOSE: The Registry to EValuate Early And Long-term Pulmonary Arterial Hypertension
(PAH) Disease Management (REVEAL) is a 54-center, observational, US-based study that …

Pulmonary vascular diseases (PVDs) are a heterogeneous group of disorders that affect the
pulmonary circulation (1). Pulmonary hypertension (PH) is one of the best studied of these …

Methods To identify pH as a contributing or underlying cause of death within the United
States between the years of 2004 and 2019, data from the Centers for Disease Control and …

1 Bermejo J, Yotti R, Garcıa-Orta R, S ánchez-Fern ández PL, Castaño M, Segovia-Cubero
J, et al. Sildenafil for improving outcomes in patients with corrected valvular heart disease …